This ERDERA webinar will explore the rules and guidance that should be followed to ensure advanced therapy medicinal product (ATMP) research complies with regulatory requirements, supporting responsible research and smooth clinical translation. Particular attention will be given to genome editing and paediatric research, two areas that raise specific regulatory considerations within the ATMP field.
The session is aimed at researchers, clinicians, regulatory professionals, ethicists and others involved in or supporting rare disease research, and forms part of the Ethics & Regulatory webinar series.
Presenter: Viviana Giannuzzi, Fondazione Gianni Benzi
Date: 30 September 2026
Time: 13:00 CET
Language: English
Materials will be made available, including a reference link to the EMA’s overview of advanced therapy medicinal products.